FERRARI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 900
EU - Europa 889
AS - Asia 318
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 2.116
Nazione #
US - Stati Uniti d'America 893
IT - Italia 338
CN - Cina 221
IE - Irlanda 193
SE - Svezia 80
SG - Singapore 63
FI - Finlandia 61
DE - Germania 58
UA - Ucraina 47
NL - Olanda 24
TR - Turchia 23
BE - Belgio 19
GB - Regno Unito 18
ES - Italia 11
RO - Romania 9
CA - Canada 7
CI - Costa d'Avorio 6
FR - Francia 6
PL - Polonia 6
AT - Austria 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
IN - India 4
JP - Giappone 3
PK - Pakistan 3
RU - Federazione Russa 3
SI - Slovenia 3
EU - Europa 2
IR - Iran 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
Totale 2.116
Città #
Chandler 208
Dublin 191
Ann Arbor 89
Parma 67
Ashburn 63
Boardman 57
Jacksonville 53
Shanghai 52
Beijing 37
Princeton 37
Singapore 34
Dearborn 33
Bremen 23
Izmir 23
Wilmington 22
Nanjing 21
Seattle 19
Bologna 17
Des Moines 14
San Polo D'enza 14
Brussels 13
Formigine 13
Trezzano Sul Naviglio 13
Jinan 12
Helsinki 11
Milan 11
Serina 11
Falls Church 10
Nanchang 10
Santa Clara 10
Barcelona 9
Polcenigo 9
Fremont 8
New York 8
San Mateo 8
Shenyang 8
Ningbo 7
Reggio Nell'emilia 7
San Giuliano Milanese 7
Abidjan 6
Changsha 6
Conversano 6
Dronten 6
Liège 6
Modena 6
Norwalk 6
Reggio Emilia 6
Warsaw 6
Woodbridge 6
Castellarano 5
Guangzhou 5
Hebei 5
Hefei 5
Pandino 5
Sorbolo 5
Tianjin 5
Fidenza 4
Hangzhou 4
Kunming 4
Lanzhou 4
Los Angeles 4
Podenzano 4
Redwood City 4
Rome 4
Scafati 4
Sesto San Giovanni 4
Toronto 4
Vienna 4
Bacoli 3
Bozzolo 3
Cambridge 3
Haikou 3
Kasuga 3
Livorno 3
Medesano 3
Montreal 3
Neviano degli Arduini 3
Southwark 3
Taizhou 3
Vigevano 3
Zhengzhou 3
Amsterdam 2
Auburn Hills 2
Boulder 2
Brno 2
Conegliano 2
Fuzhou 2
Grafing 2
Groningen 2
Jiaxing 2
Lund 2
Moudon 2
Phoenix 2
Piacenza 2
Pune 2
Rimini 2
Rockville 2
San Giovanni in Persiceto 2
Spineda 2
Taranto 2
Totale 1.479
Nome #
The third (III) road to cell transformation 130
Inhibition of human and avian type A Influenza virus multiplication by NEK-2 treatment 126
TFIIIC Binding to Alu Elements Controls Gene Expression via Chromatin Looping and Histone Acetylation 124
Retrotransposons as drivers of mammalian brain evolution 101
A composite upstream sequence motif potentiates tRNA gene transcription in yeast 87
A set of accessible enhancers enables the initial response of breast cancer cells to physiological progestin concentrations 86
Abf1 and other general regulatory factors control ribosome biogenesis gene expression in budding yeast 79
An RNA Polymerase III General Transcription Factor Engages in Cell Type-Specific Chromatin Looping 77
Distinct roles of transcription factors TFIIIB and TFIIIC in RNA polymerase III transcription reinitiation 75
TFIIIC as a Potential Epigenetic Modulator of Histone Acetylation in Human Stem Cells 74
C/EBPα mediates the growth inhibitory effect of progestins on breast cancer cells 68
A stress response factor regulates genes involved in cell growth, including Pol III-transcribed genes 67
Distinct modes of TATA box utilization by the RNA polymerase III transcription machineries from budding yeast and higher plants 65
A minimal promoter for TFIIIC-dependent in vitro transcription of snoRNA and tRNA genes by RNA polymerase III 57
Genome-wide location analysis reveals a role for Sub1 in RNA polymerase III transcription. 56
Genome-Wide Binding Map of the HIV-1 Tat Protein to the Human Genome 52
Epigenetic changes mediated by polycomb repressive complex 2 and E2a are   associated with drug resistance in a mouse model of lymphoma 48
Transcription reinitiation by RNA polymerase III 46
Transcription reinitiation properties of bacteriophage T7 RNA polymerase 43
Erratum: Correction: In vivo targeting of de novo DNA methylation by histone modifications in yeast and mouse (eLife (2015) 4 (e06205) PII: e30948) 43
In vivo targeting of de novo DNA methylation by histone modifications in yeast and mouse 43
Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis 40
Epigenetic analysis: ChIP-chip and ChIP-seq 38
null 37
Epigenetic reprogramming by adenovirus e1a 37
Hormone-control regions mediate steroid receptor–dependent genome organization 37
Mediator and SAGA have distinct roles in Pol II preinitiation complex assembly and function 36
Adenovirus small E1A employs the lysine acetylases p300/CBP and tumor suppressor RB to repress select host genes and promote productive virus infection 34
Polycomb repressive complex 1 (PRC1) disassembles RNA polymerase II preinitiation complexes 33
null 33
Histone Acetylation Regulates Intracellular pH 32
Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells 31
CONVERSION OF PROSPECTIVE HEMOGENIC ENDOTHELIUM TO CARDIOGENIC FATE IN   THE ABSENCE OF SCL/TAL1 30
Reorganization of the host epigenome by a viral oncogene 30
Scl binds to primed enhancers in mesoderm to regulate hematopoietic and cardiac fate divergence 29
Scl represses cardiomyogenesis in prospective hemogenic endothelium and endocardium 26
Modeling the regulatory network of histone acetylation in Saccharomyces cerevisiae 23
A unique epigenetic signature is associated with active DNA replication loci in human embryonic stem cells 23
Viral manipulation of the host epigenome for oncogenic transformation 22
LATS1 controls CTCF chromatin occupancy and hormonal response of 3D-grown breast cancer cells 19
Adenovirus small E1A directs activation of Alu transcription at YAP/TEAD- and AP-1-bound enhancers through interactions with the EP400 chromatin remodeler. 18
New snRNA gene-like transcriptional units as sources of regulatory transcripts 15
Transcription reinitiation properties of RNA polymerase III in the absence of transcription factors. 13
A progesterone derivative linked to a stable phospholipid activates breast cancer cell response without leaving the cell membrane 7
Loss of the DYRK1A Protein Kinase Results in the Reduction in Ribosomal Protein Gene Expression, Ribosome Mass and Reduced Translation 6
Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma 6
Totale 2.202
Categoria #
all - tutte 9.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.494


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020322 0 0 15 4 22 33 27 3 24 173 8 13
2020/2021225 9 14 25 13 36 6 18 12 44 19 23 6
2021/2022242 6 14 2 27 18 9 21 22 23 10 13 77
2022/2023737 72 83 32 54 95 71 7 47 229 13 17 17
2023/2024326 16 19 16 6 22 51 27 50 12 18 39 50
2024/2025138 18 55 65 0 0 0 0 0 0 0 0 0
Totale 2.202